The role of candesartan or carvedilol for prevention of anthracycline induced subclinical cardiotoxicity in breast cancer patients.
25 May 2019 (00:00 - 00:00)
Organised by:
About the speaker
Daejeon St. Mary's Hospital, Daejeon (Korea (Republic of))
14 More presentations in this session
Professor M. Boehm (Homburg, DE)
Doctor T. Thorvaldsen (Stockholm, SE)
Doctor W. Ouwerkerk (Amsterdam, NL)
Access the full session
The Event
Heart Failure 2019
25 May - 28 May 2019
You may be interested in
Congress Session
Congress Presentation
